1
/
of
1
ReMedium PDRN
ReMedium PDRN
Regular price
€64,00
Regular price
Sale price
€64,00
Unit price
/
per
Taxes included.
Couldn't load pickup availability
Clinical tests of this product
In the course of research, it was proved that due to the natural "leak" of concentration after the introduction of the product, the % content of PDRN and niacinamide came to an average value of 7.5% + 5%. PDRN therapy is the most popular procedure for skin rejuvenation. Polynucleotides in cosmetology are a breakthrough in terms of science and practice. Polynucleotides are incorporated into the cell, which guarantees effective rejuvenation. PDRN is isolated from enzymes of salmonids, which in turn act as "building blocks" and carry out the production of collagen. The reason for the change in the structure of the skin is a violation of the collagen framework. A massive accumulation of elastoid masses in the papillary and reticular layers of the dermis and the lack of collagen are the main signs of skin aging. And with chronoaging, they are aggravated as a result of endocrine changes.- skin tightening
- Moisturizing
- pore constriction
- rejuvenation
- Improved skin structure
- skin lightening
Effect of ReMedium PDRN
Since the product is embedded in the DNA, collagen grows actively and the skin glows, which is reflected in the figure.

The mechanism of action of PDRN
Transfer of genetic information from DNA (PDRN) to a specific protein. The DNA structural parameters of sturgeon milk and the DNA of human leukocytes are very similar. The basis is the immunomodulatory effect. Stimulates the independent production of collagen lost with age and at the same time ensures the removal of free radicals from the body.
indications
A wide range of cosmetic problems, since only this concentration of PDRN has the ability to modulate various physiological processes. (It adapts to skin types and solves many aesthetic problems, since polynucleotides are skin rehabilitators.)RegenerationLighteningSmoothing of fine wrinklesLymphatic drainage effectareas of ReMediumPDRN injection
PROCEDURE3 procedures, 1 time in 14 days.INTRODUCTION TECHNIQUELinear - retrogradeTubercularPapularHot-point techniqueResult
The patient will notice lightening and increased turgor within 24 hours. The final result can be accurately assessed after 28 days.combination with other procedures
Combination with hardware cosmetics. Rehabilitation phase after blepharoplasty and circular lifting. Treatment of stretch marks on the body in the postpartum period.mechanism of action
Long polymer chains of polynucleotides bind water molecules, improving overall hydration. The PDRN molecule is embedded in the "target", causing active tissue regeneration and activating the skin's natural processes.
The HA ReMedium PDRN advantage
The most powerful complex for skin rejuvenation. The concentration of niacinamide does not cause an allergic reaction, but is very effective for problem skin. It is a powerful whitening complex with a lifting effect. It belongs to the group of bioreparants, as it not only moisturizes the skin, but also affects the deep layers of the dermis in the fight against aesthetic problems.contraindications
Enzyme intolerance (disorder)Autoimmune diseasesFungal skin lesionsPregnancy and breastfeedingAcute respiratory diseasescomposition
Purified waterDisodium phosphate dihydrate (Na2HPO4,2H2O)Monobasic sodium phosphate dihydrateSodium chloride (NaCl)Polydeoxyribonucleotide (PDRN)NiacinamideHyaluronic acid (HA)release form
2.2 ml × 3 syringesReMedium PDRN application protocol
5-point technique
dosage and protocol
1- Highest point in the cheekbone2- Intersection of the mid-pupillary line and the line coming from the wing of the nose3- Point in the tragus of the ear4- Point of the mental area (chin)5- Point in the area of the lower jaw (exit of the nerve bundles)FACIAL PROTOCOL
Syringe 2 mlTechnique with 5 points on each side of the face 1 mlOne injection point 0.2 mlInjection of the drug into the subdermal layer of the skinNECK PROTOCOL
Syringe 2 mlTechnique with 10 points in the entire neck areaEach injection point 0.2 mlInjection of the drug into the preplatysmal fatShare
